Workers' Comp
COVID-19 Drug Therapy Treatments: Potential Impact on Workers' Comp
May 7, 2020
MIN READ
More stories
Mitchell
News Release
FDA Approval of Dsuvia: Why Now and What Might it Mean for Workers' Compensation?
The FDA recently approved a new opioid that is causing some concern.
Workers' Comp
Article
A Provider of Hope
As the holiday season approaches, many of us will drop coins in a bucket or gladly write checks to give to others in need. Though we know our dollars will help others along the way, we rarely see the direct result of the donations.
Mitchell
News Release
Marijuana Legalization Gains Ground
The legalization of marijuana marched forward on Election Day.
Workers' Comp
Article
StateWatch: Winter 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the services Genex provides.
Workers' Comp
Article
The Art of Creating a Physician Peer Review Panel - Part 1
Creating a physician peer review panel is like solving a puzzle – it comes together only after reviewing the landscape, discerning what is important, and identifying what resources are available. As in most industries, a problem or opportunity in the workers’ compensation arena first presents itself, then team members come together to share ideas and collaborate on possible solutions.
Workers' Comp
Blog
Navigating the Landscape of Drug Formularies and Prescribing and Treatment Guidelines
Over the course of the next several years we can expect more and more jurisdictions to move towards adoption of legislative and/or regulatory measures as an effort to combat the nation’s opioid crisis and to control prescription utilization and cost. Our latest video covers tools such as closed formularies and opioid prescribing limits, along with prescribing oversight measures such as treatment guidelines.